Skip to main content
Springer logoLink to Springer
. 2023 Apr 25;107(11):3653–3671. doi: 10.1007/s00253-023-12530-3

Identification of Burkholderia cenocepacia non-coding RNAs expressed during Caenorhabditis elegans infection

Tiago Pita 1, Joana R Feliciano 1,, Jorge H Leitão 1,
PMCID: PMC10175445  PMID: 37097504

Abstract

Abstract

Small non-coding RNAs (sRNAs) are key regulators of post-transcriptional gene expression in bacteria. Despite the identification of hundreds of bacterial sRNAs, their roles on bacterial physiology and virulence remain largely unknown, as is the case of bacteria of the Burkholderia cepacia complex (Bcc). Bcc is a group of opportunistic pathogens with relatively large genomes that can cause lethal lung infections amongst cystic fibrosis (CF) patients. To characterise sRNAs expressed by Bcc bacteria when infecting a host, the nematode Caenorhabditis elegans was used as an infection model by the epidemic CF strain B. cenocepacia J2315. A total of 108 new and 31 previously described sRNAs with a predicted Rho independent terminator were identified, most of them located on chromosome 1. RIT11b, a sRNA downregulated under C. elegans infection conditions, was shown to directly affect B. cenocepacia virulence, biofilm formation, and swimming motility. RIT11b overexpression reduced the expression of the direct targets dusA and pyrC, involved in biofilm formation, epithelial cell adherence, and chronic infections in other organisms. The in vitro direct interaction of RIT11b with the dusA and pyrC messengers was demonstrated by electrophoretic mobility shift assays. To the best of our knowledge this is the first report on the functional characterization of a sRNA directly involved in B. cenocepacia virulence.

Key points

• 139 sRNAs expressed by B. cenocepacia during C. elegans infection were identified

• The sRNA RIT11b affects B. cenocepacia virulence, biofilm formation, and motility

• RIT11b directly binds to and regulates dusA and pyrC mRNAs

Supplementary Information

The online version contains supplementary material available at 10.1007/s00253-023-12530-3.

Keywords: Burkholderia cenocepacia, C. elegans infection model, RNA-seq, Non-coding RNAs

Introduction

The Burkhoderia cepacia complex (Bcc) comprises at least 24 Gram-negative Betaproteobacteria species (Martina et al. 2018), all of them able to colonise and infect immunocompromised individuals and cystic fibrosis (CF) patients. The clinical outcome of Bcc infections is highly variable and strain-dependent, in some cases leading to a clinical condition of lethal uncontrolled deterioration with septicaemia and necrotising pneumonia, known as the cepacia syndrome (Golshahi et al. 2011; Leitão et al. 2017). Bcc strains are intrinsically resistant to most antibiotics (Rhodes and Schweizer 2016), turning those infections difficult to eradicate. Burkholderia cenocepacia and Burkholderia multivorans are the most predominant Bcc species infecting CF patients worldwide (Hassan et al. 2020). B. cenocepacia possess a large genome (approximately 8 Mb), composed by multiple replicons, the chromosome 1 (3.9 Mb), chromosome 2 (3.2 Mb), megaplasmid pC3 (0.88 Mb), and plasmid pBCJ2315 (92 kb) (Holden et al. 2009). At least 7261 coding sequences, six sets of rRNA genes, and 74 tRNAs are annotated in the genome of B. cenocepacia J2315, the representative member of the epidemic ET12 lineage that was isolated from a CF patient (Holden et al. 2009). Other regulatory non-coding sequences, like small non-coding RNAs (sRNAs), are also present within the B. cenocepacia genome; however, these RNA molecules remain poorly characterised and their study in the context of infection is almost non-existent (Pita et al. 2018).

Small non-coding RNAs (sRNAs) emerged as major regulators of physiological processes in bacteria and play important roles on their virulence. The post-transcriptional regulation mediated by sRNAs is particularly important for bacterial pathogens, since these RNA molecules can modulate their target gene expression allowing a fast response towards an efficient adaptation to a challenging and dynamic host environment. The stability and function of these regulatory RNAs often require RNA chaperones, like the proteins Hfq and ProQ (Feliciano et al. 2020; Djapgne and Oglesby 2021). Pseudomonas aeruginosa, an organism that is also responsible for severe infections amongst CF patients, possesses several characterised sRNAs involved in regulating key mechanisms for its virulence and pathogenicity, including quorum sensing, iron homeostasis, biofilm formation, response to stress, and host cell invasion (Pusic et al. 2021). In B. cenocepacia, 167 putative sRNAs were identified under conditions like growth in CF sputum medium, biofilm formation, and oxidative stress, and very few have been functionally characterised so far (Pita et al. 2018). These include the ncS35 sRNA, which attenuates the growth and reduces the metabolic rate of B. cenocepacia J2315 (Kiekens et al. 2018); the ncS27 sRNA that can regulate the metabolic shutdown upon nutrient deprivation (Sass et al. 2019); and BrrF that acts as a regulator of central metabolism and oxidative stress response under iron starvation conditions (Sass and Coenye 2020). Despite the deadly threat of Bcc infections amongst immunocompromised and CF patients, the virulence and unpredictable outcome of Bcc infections remain uncertain and the contribution of sRNAs to Bcc virulence is unknown.

The well-studied organism Caenorhabditis elegans has been widely used as a model to study host–pathogen interactions. This animal is genetically well characterised and represents a good model for research due to its experimental simplicity, low cost, and easy handling without raising major ethical concerns (Sánchez-Diener et al. 2017). Furthermore, at least 83% of the C. elegans proteome has human homologous genes (Lai et al. 2000), and several studies have been carried out on C. elegans to unveil some features of CF pathogens, like P. aeruginosa and Bcc bacteria. Some Bcc bacteria have been proven to be virulent to C. elegans (Cooper et al. 2009), and a list of genes required for B. cenocepacia survival within the host-associated environment has been already identified (Wong et al. 2018). More recently, sRNAs have been shown to be involved in C. elegans avoidance behaviour of P. aeruginosa (Kaletsky et al. 2020), evidence that highlights the wide role of sRNAs on host-microbe interaction. C. elegans was also used to decipher the Vibrio parahaemolyticus virulome, and 19 trans-encoded sRNAs were found to be differentially expressed under infection conditions (Zhang et al. 2020). The most advanced techniques of RNA sequencing have allowed the identification and accurate gene quantification of the entire transcriptome for samples with low inputs of RNA, enabling the bacterial transcriptome analysis under infection conditions (Marsh et al. 2017; Hassan et al. 2019).

In the present work, an experimental methodology was developed, involving the recovery of total RNA from B. cenocepacia J2315 infecting C. elegans, followed by RNA sequencing, to identify the B. cenocepacia J2315 sRNAs expressed under infection conditions. Amongst the 108 new and 31 previously described sRNAs, the RIT11b sRNA was functionally characterised in this work. Results show that this regulatory RNA plays a role in B. cenocepacia virulence in C. elegans, affecting biofilm formation and swimming motility.

Materials and methods

Bacterial strains, plasmids, and culture conditions

Bacterial strains and plasmids used in this study are described in Table 1. When in use, B. cenocepacia and Escherichia coli strains were maintained on Lennox broth (LB; containing in g·L−1, tryptone 10, yeast extract 5, NaCl 5) agar plates, supplemented with 200 μg·mL−1 chloramphenicol (B. cenocepacia), 25 μg·mL−1 chloramphenicol, or 150 μg·mL−1 ampicillin (E. coli), when appropriate. Unless otherwise stated, liquid cultures were carried out in LB liquid medium supplemented with the appropriate antibiotics with orbital agitation (250 rpm), at 37 °C. Bacterial growth was assessed by measuring the cultures optical density at 640 nm (OD640).

Table 1.

Organism strains and plasmids used in this work

Organism or plasmid Description Reference or source
C. elegans strains
C. elegans Bristol N2 C. elegans wild isolate Caenorhabditis Genetics Center (CGC)a
C. elegans DH26 C. elegans with a temperature-sensitive mutation, rrf-3(b26) II, rendering worms sterile at 25 °C Caenorhabditis Genetics Center (CGC)a
Bacterial strains
B. cenocepacia J2315 (LMG16656) Cystic fibrosis clinical isolate (Edinburgh, UK); ET12 lineage reference strain Govan et al. (1993)
B. cenocepacia K56-2 (LMG18863) Cystic fibrosis clinical isolate (Toronto, Canada); ET12 lineage Darling et al. (1998)
Escherichia coli DH5α F φ80lacZΔM15Δ (lacZYAargF) U169 recA1 endA1 hsdR17 (rK, mK+) phoA supE44 λthi-1 gyrA96 relA1 Invitrogen (Waltham, MA, USA)
E. coli BL21 (DE3) F ompT hsdSB (rBmB) dcm gal λ(DE3) Stratagene (La Jolla, CA, USA)
E. coli OP50 C. elegans feeding strain Caenorhabditis Genetics Center (CGC)a
Plasmids
pUC19 Cloning vector; high copy number; lac promoter; AmpR; multiple cloning site located within the lacZ gene Yanisch-Perron et al. (1985)
pIN29 oripBBR Δmob, Cmr, DSRed Vergunst et al. (2010)
pTAP3 pIN29 overexpressing RIT11b under control of tac promoter This work
pTAP4 pIN29 overexpressing RIT32 under control of tac promoter This work
pTAP5 pIN29 overexpressing RIT55 under control of tac promoter This work
pTAP9 pIN29 containing the antisense sequence for RIT2a silencing This work
pTAP10 pIN29 containing the antisense sequence for RIT98 silencing This work
pTAP11 pIN29 containing the antisense sequence for RIT43 silencing This work

aThe Caenorhabditis Genetics Center (CGC), University of Minnesota, https://cgc.umn.edu/

Plasmids

Plasmids and primers used in this work are listed in Table 1 and Supplemental Table S1, respectively. To silence the RIT2a, RIT43, and RIT98 sRNAs, a fully complementarity antisense strategy was used, cloning an antisense sequence of each sRNA (38 to 40 bp) in the pIN29 plasmid under control of the tac promoter. The two single-stranded oligonucleotides with complementary sequences (RIT2asilencFW and RIT2asilencRV; RIT98silencFW and RIT98silencRV; RIT43silencFW and RIT43silencRV) were annealed to form a double-strand DNA sequence. For this, each oligonucleotide was diluted to a final concentration of 100 µM using the annealing buffer (10 mM Tris, pH 8.0; 50 mM NaCl; 1 mM ethylenediaminetetraacetic acid [EDTA]). Equal volumes of the equimolar oligonucleotides were mixed and incubated at 95 °C for 5 min to break all the hydrogen bonds. The reaction mixture was allowed to cool slowly to room temperature (< 60 min). The double-strand sequences were inserted into the pUC19 cloning vector previously linearised with the HincII restriction enzyme (Thermo Scientific, Waltham, MA, USA). After sequencing, each plasmid was digested with NdeI/XbaI, and the resulting fragments were inserted into the pIN29 plasmid yielding the pTAP9, pTAP10, and pTAP11 plasmids. Plasmids pTAP9, pTAP10, and pTAP11 were used to silence, respectively, RIT2a, RIT98, and RIT43.

The overexpression of RIT11b, RIT32, and RIT55 sRNAs was achieved by cloning the entire sequence of each sRNA into the pIN29 plasmid and expressing it under the control of the tac promoter. For this purpose, nested PCRs were performed using the outside primers RIT11bNestFW and RIT11bNestRV, RIT32NestFW and RIT32NestRV, or RIT55NestFW and RIT55NestRV, for the first round of amplifications, and, respectively, the inner primers RIT11bSupFW and RIT11bSupRV, RIT32SupFW and RIT32SupRV, or RIT55SupFW and RIT55SupRV, for the second amplification. The resulting 411-bp amplicon containing RIT11b sequence, the 118-bp fragment containing RIT32, and the 223-bp fragment containing RIT55 were digested with NdeI/XbaI and cloned into the same restriction sites of the pIN29 vector, yielding the pTAP3, pTAP4, and pTAP5 plasmids, respectively. Plasmids pTAP3, pTAP4, and pTAP5 were used to overexpress, respectively, RIT11b, RIT32, and RIT55.

Biofilm formation assay

The biofilm formation ability by B. cenocepacia was assessed based on the crystal violet assay method previously described (Cunha et al. 2004). Briefly, 96-well polystyrene microtitre plates (Greiner Bio-One, Kremsmünster, Austria) containing LB liquid medium were inoculated with mid-exponential phase bacterial cultures using an initial OD640 of 0.05 and incubated at 37 °C for 24 or 48 h without agitation. After gentle washing the wells three times, the adherent cells were stained with a crystal violet solution (1% w/v) for 15 min before a new washing step. Biofilm quantification was performed after dissolving bound crystal violet in 95% ethanol and measuring the absorbance at 590 nm in the microplate reader SpectroStar Nano (BMG Labtech, Ortenberg, Germany). Results are mean values ± SD of at least 12 replicates from 3 independent experiments. Changes in biofilm formation were analysed by two-way ANOVA with a Sidak’s multiple-comparison test using GraphPad Prism version 6.0 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com).

Swimming motility assays

Swimming motility assays were performed according to methods previously described (Déziel et al. 2001). Briefly, swimming agar plates (1% [w/v] tryptone, 0.5% [w/v] NaCl, 0.3% [w/v] agar) were spot inoculated with 1.5 μL of an overnight bacterial culture at the stationary phase, adequately diluted to obtain an OD640 of 2.0. Plates were incubated for a period of 72 h at 37 °C, and the halo diameters were measured at 24-h intervals. Results are mean values ± SD of 3 independent assays, using 5 plates per experiment and per strain. Changes in swimming motility formation were analysed by two-way ANOVA with a Tukey’s multiple-comparison test using GraphPad Prism version 6.0 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com).

C. elegans maintenance and synchronization

C. elegans strains Bristol N2 (wild-type) and DH26 (a mutant carrying a temperature-sensitive spermatogenesis mutation) were obtained from the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, USA) (Brenner 1974). Both strains were maintained at 20 °C on Nematode Growth Medium I plates (NGM I: 1.7% [w/v] agar, 50 mM NaCl, 0.35% [w/v] tryptone, 25 mM KH2PO4, 1 mM CaCl2, 1 mM MgSO4, 5 μg·mL−1 cholesterol, 2 μg·mL−1 uracil, and 50 μg·mL−1 of the antifungal nystatin), with the E. coli strain OP50 as a food source, and manipulated using established techniques (Hope 1999).

C. elegans cultures were synchronised using a well-established procedure (Hope 1999). Briefly, adult worms and eggs were washed off from an NGMI plate with sterile water, and one third of the volume of a sodium hypochlorite (4% [w/v]) and sodium hydroxide (1.6 M) solution was added. The mixture was vigorously vortexed for 5 to 7 min to isolate the hypochlorite-resistant eggs, and after two washing steps with sterile water, the pellet was resuspended in M9 buffer and transferred to NGM I plates seeded with E. coli OP50. The plates were incubated at 20 °C to allow the growth of the nematodes until the L4 larval stage.

Lethality assays

To assess the relative virulence of B. cenocepacia K56-2 overexpressing sRNAs RIT11b, RIT32, or RIT55, or silencing sRNAs RIT2a, RIT43, or RIT98, nematode slow-killing assays were performed based on the methods described by Cardona et al. (2005), using the C. elegans mutant strain DH26. For this purpose, 50 μL of B. cenocepacia cultures at the stationary phase, grown in LB liquid medium during 16 h at 37 °C with agitation (250 rpm), was spread onto the surface of 35-mm-diameter Petri plates containing 4 mL of NGM II agar (1.7% [w/v] agar, 50 mM NaCl, 0.25% peptone, 25 mM KH2PO4, 1 mM CaCl2, 1 mM MgSO4, 5 μg·mL−1 cholesterol, 2 μg·mL−1 uracil, and 50 μg·mL−1 of the antifungal nystatin) and incubated for 24 h at 37 °C to achieve the formation of a bacterial lawn. Approximately 20–30 hypochlorite-synchronised L4 larvae of C. elegans DH26 were inoculated per plate and incubated at 25 °C. The morphological appearance and the number of live worms were checked each 24 h for 3 days. Worms were considered dead when they failed to respond to touch.

C. elegans colonization and intestinal bacteria recovery for bacterial RNA-seq

C. elegans Bristol N2 was used as the animal model to assess the transcriptome of B. cenocepacia J2315 under conditions mimicking a persistent infection. For that, 100 μL of overnight culture of B. cenocepacia J2315, grown in LB liquid medium at 37 °C with agitation (250 rpm), was spread onto the surface of 100-mm-diameter Petri plates containing 22 mL of NGM II agar and incubated for 24 h at 37 °C to achieve the formation of a bacterial lawn. Hypochlorite-synchronised C. elegans Bristol N2 larvae were used and maintained in plates with heat-inactivated E. coli (80 °C for 30 min) to avoid contamination of the posterior RNA samples with E. coli nucleic acids. No colony forming units (CFUs) were obtained after plating heat-treated E. coli suspensions. Once the larvae reached the L3 stage, M9 buffer was used to collect them and 25,000 nematodes were inoculated per plate seeded with B. cenocepacia and incubated at 25 °C. A total of 12 plates were used, totalising 300,000 nematodes. After 48 h of infection, the nematodes were collected with M9 buffer, double filtrated with nylon net filters (Merck Millipore, Burlington, MA, USA), and washed 2 times with M9 buffer. The 41-µm pore filter was used to retain the large external bacterial agglomerates whereas the 10-µm pore filter was used to collect the infected C. elegans and eliminate the external free bacteria. The nematodes were directly and promptly collected from the filter with TRIzol™ Reagent (Invitrogen, Waltham, MA, USA) and vortexed vigorously until complete homogenization was achieved. B. cenocepacia J2315 cells plated on NGMII agar plates as previously described, but in the absence of the nematodes, were used as control.

Colony forming unit quantification

To determine the B. cenocepacia CFUs present in infected C. elegans, the nematodes were collected by filtration after 48 h of infection, as previously described. The nematodes were directly collected from the filter using 1 mL M9 buffer and were quantified by direct counting using a stereomicroscope. The same volume was collected to determine the number of external bacteria (unprocessed samples) and the total bacteria associated with the infected nematodes (present both outside and inside the worms). To count the external bacteria, the collected volume was only homogenised, whilst to estimate the total number of bacteria approximately 400 mg of 1.0-mm silicon carbide particles (Biospec, Bartlesville, OK, USA) was added to the samples and vigorously vortexed for 10 min. The resulting suspensions were diluted and plated onto LB media for CFU quantification. CFUs inside C. elegans were calculated by subtracting the external CFUs to the CFUs of C. elegans lysed by bead samples (total CFUs). CFUs were expressed as CFUs/C. elegans.

RNA extraction and sequencing

Total RNA extraction was performed with the reagent TRIzol™ following the manufacturer’s instructions. After extraction, the RNA samples were sent to the company Vertis Biotechnologie AG (Freising, Germany), where a ribosomal RNA extraction was performed using the Ribo-Zero rRNA Removal Kit (Illumina®, San Diego, CA, USA) using a 1:1 ratio of probes from the Human/Mouse/Rat and Bacteria module. The bacterial RNA enrichment was achieved using the Cappable-seq for prokaryotic transcription start site (TSS) determination (New England Biolabs® Inc., Ipswich, MA, USA). This method consists of capping the 5′ triphosphorylated RNA with 3′-desthiobiotin-TEG-guanosine 5′ triphosphate (DTBGTP) (New England Biolabs® Inc., Ipswich, MA, USA) using the vaccinia capping enzyme (VCE) (New England Biolabs® Inc., Ipswich, MA, USA) for reversible binding of biotinylated RNA species to streptavidin. Using this approach, the 5′ fragment of the primary transcripts was obtained.

The Cappable-seq enriched RNAs were first poly(A)-tailed using poly(A) polymerase. Then, the 5′PPP structures were converted into 5′ monophosphate ends using CapClip acid pyrophosphatase (Cellscript, Madison, WI, USA). Afterwards, an RNA adapter was ligated to the 5′-monophosphate of the RNA. First-strand cDNA synthesis was performed using an oligo(dT)-adapter primer and the M-MLV reverse transcriptase. The resulting cDNAs were PCR-amplified to about 10–20 ng/μL using a high-fidelity DNA polymerase. PCR cycles performed and barcode sequences, which are part of the 5′ and 3′ sequencing adapters, are included in Supplemental Table S2. The cDNAs were purified using the Agencourt AMPure XP kit (Beckman Coulter Genomics, Indianapolis, IN, USA) and analysed by capillary electrophoresis. For Illumina NextSeq sequencing, the cDNA libraries were pooled in approximately equimolar amounts. The cDNA pool was size fractionated in the size range of 200–550 bp using a preparative agarose gel. The 3′ and 5′ adapters and the primers used for PCR amplification were designed for TruSeq sequencing according to the instructions of Illumina (Supplemental Table S2). The cDNA pool was single-read sequenced on an Illumina NextSeq 500 system using 75-bp read length. The Array Express accession number for Cappable-seq data is E-MTAB-12592. Principal component analysis and the heatmap were performed with the ClustVis web tool (https://biit.cs.ut.ee/clustvis/), using the default parameters.

Transcription start site annotation and classification

The NCBI genome database (Sayers et al. 2021) and the Burkholderia genome database (Winsor et al. 2008) were used for B. cenocepacia J2315 genome visualization and annotation. Cappable-seq data was visualised with the Integrated Genome Viewer version 2.1.1.8 (Thorvaldsdóttir et al. 2013). Mapping output from Cappable-seq was split by replicon and converted to BAM files using SAMtools 1.14 (Li et al. 2009). BEDtools 2.25.0 (Quinlan and Hall 2010) was also used on TSS calling. TSS calling and clustering were performed using the data obtained from controls and infection samples using a previously developed programme on Linux system (Ettwiller et al. 2016). TSS clustering was performed at a neighbourhood of 10 reads. A TSS was considered when, in at least 2 samples, RRSio > 2. RRSio, the relative read score that reflects the strength of each TSS (Ettwiller et al. 2016), was the normalization adopted in this data analysis. Matching the TSSs with B. cenocepacia J2315 genome annotation allowed the categorization of the TSSs as gene TSS (TSS located up to 100 nts upstream of a gene), 5′ UTR TSS (TSS located from 100 to 300 nts upstream of a gene), or intergenic TSS (TSS located over 300 nts from a gene). sRNA identification was performed by matching the intergenic TSSs with the rho-independent terminators obtained by TransTerm v2.08, using the default parameters (Kingsford et al. 2007).

Differential expression analysis

Differential expression analysis was performed identifying the genes whose TSS normalised read counting was higher than fold change (log2) of 2 between the controls and samples. The KEGG (https://www.genome.jp/kegg/kegg1.html) enrichment analysis was performed using the KOBAS software (Bu et al. 2021) by entering the UniProtKB accession number of all the differently expressed genes, and using the default parameters.

Target prediction and statistical analysis

TargetRNA2 (Kery et al. 2014) and CopraRNA (Wright et al. 2014) were used for sRNA target prediction (using the default parameters, except for the target input parameters that were defined from 300 nucleotides [nts] upstream to 100 nts downstream of the mRNA translation start site), whilst IntaRNA 2.0 (Mann et al. 2017) was used for an accurate prediction of interactions between a sRNA and a predicted target. NCBI Blastn (Sayers et al. 2021) was used to evaluate sRNA conservation. The statistical analysis of raw RNA-seq data results was performed using the ClustVis web tool with default function parameters (Metsalu and Vilo 2015). GraphPad Prism version 6.0 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com) was used for data statistical analysis and graph design.

Quantitative RT-PCR

For quantitative RT-PCR, RNA was extracted using the Quick-RNA™ Miniprep Kit (Zymo Research, Irvine, CA, USA) following the manufacturer’s instructions. An additional step of DNAse I treatment was included after the total RNA purification. Extracted RNA was analysed in a 1% agarose TBE (tris-2-amino-2-hydroxymethyl-propane-1,3-diol/borate/EDTA; 10 × TBE contains, in g·L−1, 121 Tris-base, 61.8 boric acid, and 7.4 EDTA) gel to assess its quality and the concentration was quantified in NanoDrop One (Thermo Scientific, Waltham, MA, USA) spectrophotometer. cDNA was synthesised from 2 μg RNA using a NZY Reverse Transcriptase (NZYTech, Lisbon, Portugal) and random hexamers (NZYTech, Lisbon, Portugal), following the protocol established by the manufacturer. Quantitative RT-PCR (qPCR) was performed in an Applied Biosystems QuantStudio 5 Real-Time PCR System, using the NZYSpeedy qPCR Green Master Mix (a 2 × ready-to-use reaction mixture containing all components necessary for real-time PCR, including a green intercalating dye, dNTPs, stabilisers, and enhancers, as per manufacturer description) from NZYTech (Lisbon, Portugal), ROX (NZYTech, Lisbon, Portugal). Each reaction contained 100 ng of cDNA, 400 nM of each specific primer (Supplemental Table S1), and the NZYSpeedy qPCR Green Master Mix. A calibration curve was performed for each pair of primers and every sample was run in two technical replicates. Relative expression was calculated with the 2−ΔΔCT method (Livak and Schmittgen 2001) using the 5S rRNA for normalization. Changes in expression were analysed by one-way ANOVA with a Tukey’s multiple-comparison test using GraphPad Prism version 6.0 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com).

In vitro transcription and electrophoretic mobility shift assay

The DNA fragments used as templates for in vitro transcription of the RIT11b sRNA, BCAL1625 (nucleotides − 39 to 89), and BCAL3351 (nucleotides − 53 to 107) RNAs were amplified from B. cenocepacia genome using forward primers containing the T7 promoter at the 5′ end (Supplemental Table S1). RNA sequences were transcribed in vitro using the MEGAscript T7 kit (Ambion, Waltham, MA, USA) with native UTP for RIT11b, or native UTP and Biotin-16-UTP (Roche, Basel, Switzerland) (2:1) for BCAL1625 and BCAL3351 RNAs, followed by DNase I digestion (1 unit) for 30 min at 37 °C. The RNA synthesised was purified on a denaturing gel. For that, the RNA was separated on a denaturing 6% polyacrylamide gel (1 × TBE, 7 M urea), stained with ethidium bromide, and visualised by UV shadowing. The area of the gel expected to contain the band of RNA was cut and soaked in elution buffer (0.1 M sodium acetate, 10 mM EDTA, and 0.1% SDS) overnight with rocking at 8 °C. The RNA was precipitated with 0.1 volume of sodium acetate 3 M, pH 5.2 and 3 volume ethanol, and resuspended in RNAse-free water.

The interactions between the unlabelled sRNA RIT11b and the labelled BCAL1625 or BCAL3351 RNAs were assessed using mobility shift assays with increasing amounts of the unlabelled sRNA and a fixed concentration of the labelled RNAs (0.04 pmol). Labelled RNAs, previously denatured for 1 min at 95 °C and cooled for 5 min on ice, were mixed in a total volume of 10 µL with 1 µg yeast tRNA (Ambion, Waltham, MA, USA) and increasing amounts of unlabelled sRNA in structure buffer (10 mM Tris‐HCl pH 7.5, 100 mM KCl, 10 mM MgCl2). The reaction mixtures were incubated at 37 °C for 30 min and mixed with 2 µL of native loading dye (50% [v/v] glycerol, 0.25% [w/v] bromophenol blue, 0.25% [w/v] xylene cyanol FF) immediately before loading on 6% polyacrylamide, 0.5 × TBE (diluted from 10 × TBE) gels. After electrophoresis on 6% polyacrylamide (250 V, 4 °C), samples containing biotin-labelled RNA were electroblotted to Amersham Hybond™-N+ positively charged nylon transfer membranes (GE Healthcare, Chicago, IL, USA) using a transBlot® SD (Bio-Rad, Hercules, CA, USA) device at 15 V and 220 mA for 50 min. Labelled RNA was detected by chemiluminescence using a Pierce Chemiluminescent Nucleic Acid Detection Module kit (Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s instructions.

Results

Development of a model for bacterial transcriptional analysis using C. elegans infected by B. cenocepacia J2315

In our attempt to investigate the B. cenocepacia non-coding RNA repertoire expressed when infecting the host, the nematode C. elegans was used and infected by B. cenocepacia J2315, and a protocol to analyse the bacterial transcriptome during infection was developed. Important bottlenecks had to be overcome, including the large amount of C. elegans required for infection, the elimination of the external bacteria collected with the nematodes, and the speed of sample collection to avoid transcriptional adaptation. In brief, after egg preparation via culture synchronization, recovered eggs were seeded in NGMI plates with heat-killed E. coli to guarantee that the worms do not get their gut colonised by E. coli. The infection process started when nematodes in L3 larval stage were harvested and poured on plates containing previously grown B. cenocepacia J2315. The use of a 10-µm pore size filter to collect the infected C. elegans failed to discard all external bacteria, present both in a free-living form and as clusters attached to the nematodes. Therefore, an extra filtration step by a 41-µm pore size filter was added to the process, allowing the passage of the nematodes through the filter and the retention of the bacterial clusters. In the established methodology the 48-h infected C. elegans were submitted to the described double filtration, first using 41-µm pore size filter to discard bacterial clusters, and then using a 10-µm pore size filter to retain the nematodes and separate them from free bacteria. When collected, C. elegans were, on average, infected with 6 × 103 CFUs/worm, a value in accordance with literature (Palominos and Calixto 2020). About 300,000 nematodes were used per replicate, to obtain a total of ~ 109 CFUs per sample. After filtration, the filter-recovered C. elegans were immediately poured in TRIzol reagent, stopping all enzymatic activity.

The use of sodium azide and gentamicin, described by others (Zhang et al. 2020), were not used in this work. Instead, the use of the described mechanical procedures guarantees a fast and biocide-free recovering, which minimise alterations on bacterial transcriptome. Despite this, a slightly higher number of bacteria externally attached to the nematodes were collected, but this number is still less than 10% of the total number of bacteria counted inside the C. elegans. An illustrative scheme of the protocol developed for the extraction of the B. cenocepacia RNA under conditions of infection is shown in Fig. 1. B. cenocepacia growing in NGM II plates under the conditions described for the infections assay were also collected to be used as control.

Fig. 1.

Fig. 1

Schematic representation of the methodology implemented to infect C. elegans nematodes with B. cenocepacia J2315 and recover total RNA to study the bacterial transcriptome in conditions of infection. Abbreviations: CDS, coding sequences; 5′ UTR, 5′ untranslated region

The transcriptome of B. cenocepacia J2315 under infection conditions

Determining transcription start sites

After extraction, the total RNA of controls and infection samples was examined by capillary electrophoresis to check the general quality of the samples and the estimated ratio of bacterial/eukaryotic RNA (Supplemental Fig. S1A). The RNA profiles of samples from bacteria infecting the C. elegans were distinct from the RNA profiles of bacteria growing in NGMI medium, and like those of C. elegans (Supplemental Fig. S1A). These results suggest that RNA samples from infecting bacteria contained a scarce amount of bacterial RNA compared to the RNA of the eukaryotic host. After ribosomal RNA depletion, 5 to 10% of the RNA from both samples and controls were recovered (Supplemental Table S3). This is in agreement with other studies showing that ribosomal RNA accounts for more than 90% of the total RNA in a cell (Sawana et al. 2014). Approximately 0.2% of the total RNA was recovered after the enrichment of the samples in bacterial RNA. This was expected considering the abundance of eukaryotic RNA in samples from the infection process.

To evaluate the RNA-seq data, a gene expression principal component analysis (PCA) plot was performed and a heatmap was generated, providing insights into the association between all the samples analysed (Fig. 2A and Supplemental Fig. S1B). A clear differentiation is observed between samples from the bacteria infecting C. elegans (S samples) and the controls (C samples). All the C samples presented a significant similarity regarding the first two principal components, whilst sample S3 from the infection experiments was less correlated with the samples S1 and S2, probably due to the smaller number of reads. Although about 7 to 9 million raw and trimmed reads were obtained for each control or infection sample (Supplemental Table S4), the number of mapped reads against the B. cenocepacia J2315 reference genome decreased significantly in all the infection samples (less than 8% of the trimmed reads), indicating the predominance of eukaryotic RNA in these samples even after the enrichment in bacterial RNA. Figure 2B shows a clear difference between the mapped reads of the controls and infection samples.

Fig. 2.

Fig. 2

Quality control and characterization of B. cenocepacia J2315 Cappable-seq dataset. A Principal component analysis (PCA) plots of control and infection samples. B Read counting: total, trimmed, and reads mapped to the reference genome of B. cenocepacia J2315. C Number of TSSs obtained per replicon: gene – TSS located up to 100 nt upstream of a gene, 5′ UTR – TSS located from 100 to 300 nt upstream of a gene, intergenic – TSS located over 300 nts upstream of a gene. D Percentage of gene-related TSSs upregulated (twofold), unchanged (any difference in expression level or no expression), and downregulated (twofold) on infection conditions in each replicon. E KEGG pathways overrepresented by the altered genes of B. cenocepacia J2315 infecting C. elegans N2. S1, S2, S3 – B. cenocepacia J2315 samples collected from C. elegans after 48 h of infection. C1, C2, C3 – B. cenocepacia J2315 control samples grown on NGMII agar plates. The Fisher’s exact test was used to determine the statistical significance of the results and the calculated p-value is represented by * when p-value < 0.05, ** when p-value < 0.01, and *** when p-value < 0.001

Considering the limitations of B. cenocepacia J2315 genome annotation to identify the coding and non-coding transcriptome, we initiated data analysis by identifying TSSs. The identification of TSSs was initially performed for controls, since a higher and more reliable number of reads were mapped to the B. cenocepacia J2315 reference genome.

A total of 8695 TSSs were identified with the established criteria (Supplemental Table S5). The majority of the TSSs were located in chromosomes 1 and 2 on the putative 5′ UTRs. TSSs located up to 100 nts upstream a coding sequence (gene TSS) were the less abundant (Fig. 2C). The identification of intergenic TSSs is particularly interesting since they can represent important but non-annotated genes, like non-coding RNAs. Curiously, intergenic TSSs represent the majority of the identified TSSs in B. cenocepacia J2315 megaplasmid pC3 and plasmid pBCJ2315 (Fig. 2C). We hypothesise that this either might result from a poor annotation of these replicons or might reflect a higher ratio of non-coding sequences in these replicons. Despite the high number of TSSs obtained in this work, most probably resulting from the presence of alternative TSSs, only 2584 annotated genes were identified, which correspond to 35% of all B. cenocepacia annotated genes (Supplemental Table S6). Of the 2584 annotated genes identified, 667 genes show multiple TSSs in our dataset. This might result from the presence of genes, namely non-coding RNAs, without a clear terminator or the presence of primary and secondary TSSs. Different transcripts for the same annotated gene have been reported to be expressed under different environmental conditions, probably reflecting the high adaptability of bacteria (Mejía-Almonte et al. 2020). Interestingly, the TSSs identified in our dataset suggest that different transcripts of some B. cenocepacia genes are expressed in controls and infection samples. Also of notice is that some genes have a TSS highly expressed in control and downregulated in the infection samples, whilst TSSs scarcely expressed in the control were found upregulated in the infection samples (Supplemental Table S6). These results evidence a selective expression of distinct transcripts under different environments. One such example is the BCAL1887 gene that codes for the nucleoside diphosphate kinase Ndk: the expression of the TSS located 227 nts upstream of the start codon is increased 16 times in infection samples compared to control samples, whilst the TSS located 40 nts upstream of the start codon is 5 times less expressed in infection samples than in the control samples (Supplemental Table S6).

Revealing the coding transcriptome

To unveil genes differently expressed under infection conditions, a comparison of normalised values of gene expression between control and infection samples was performed. Figure 2D shows that the expression levels of most of the annotated genes remained unchanged in bacteria infecting the C. elegans, including those not detected in the infection sample dataset. Nevertheless, a considerable percentage of genes presented significant changes in their expression levels. The percentage of dysregulated genes decreased according to their location, respectively, in chromosomes 1 and 2, megaplasmid pC3, and plasmid pBCJ2315. The expression of almost 38% of the genes located in chromosome 1 was significantly altered in infection samples, most of them being upregulated.

After 48 h of C. elegans infection, the most significantly affected pathways detected in B. cenocepacia were the biosynthesis of secondary metabolites and the biosynthesis of antibiotics (p-value < 0.001) (Fig. 2E). These pathways are involved mainly in the production of non-essential molecules for bacterial survival, but are of critical importance for environment interactions (Pandey et al. 2021). In this work, a KOBAS software gene-list enrichment analysis showed that most of the genes identified by Wong et al. (2018) as essential for B. cenocepacia growth on NGMI and survival in C. elegans also belong to the KEGG pathways related with the biosynthesis of secondary metabolites and biosynthesis of antibiotics (Supplemental Table S7) (Wong et al. 2018). In addition, a significant number of the genes here identified as differently expressed in infection conditions match to those identified by Wong et al. (2018) as essential for B. cenocepacia survival in C. elegans (Fisher statistic test, p-value < 0.05).

Genes previously identified as virulence factors of B. cenocepacia were found to be differently expressed in B. cenocepacia J2315 during C. elegans infection. The majority were upregulated (22 genes out of the 29 differently expressed virulence factors) and some of them are involved in processes related with bacteria sensing and interaction with the surrounding environment, namely two-component systems (e.g. ompR), quorum sensing (e.g. rpfR and cepI), and bacterial secretion systems (e.g. virB1 and gspD) (Supplemental Table S6). The extracytoplasmic function sigma factors orbS (BCAL1688) and ecfD (BCAL2360), two major transcriptional regulators in response to environmental changes (de Dios et al. 2021), were found more than 6 times upregulated (Supplemental Table S6). Curiously, the genes that code for the Hfq chaperone (BCAL1879) and the acyl carrier protein AcpP (BCAL0995 and BCAL2875), previously described by our research group as essential for Bcc full virulence in C. elegans (Sousa et al. 2008, 2010), were found to be upregulated in B. cenocepacia J2315 during C. elegans infection (Supplemental Table S6). The LysR family protein ShvR, a pleiotropic regulator (Subramoni et al. 2011; Gomes et al. 2018), was also found to be downregulated in B. cenocepacia during C. elegans infection (Supplemental Table S6).

Non-coding RNA identification and characterization

To identify the non-coding RNAs expressed by B. cenocepacia when infecting C. elegans, the identified 5′UTR and intergenic TSSs were matched with the predicted rho-independent terminators, since sRNAs are generally terminated by this type of terminators (Chen et al. 2019). To maximise the number of identified sRNAs, all the TSSs identified in controls (8695) (Supplemental Table S5) and infection samples (186) were considered (Supplemental Table S8). This analysis led us to identify 130 putative sRNAs for 100 rho-independent terminators (Supplemental Table S9). In addition to the 130 putative sRNAs, sRNAs already annotated on NCBI database, were also found as expressed under infection conditions (Supplemental Table S6). A total of 108 putative sRNAs, corresponding to 83 rho-independent terminators, are described here for the first time. The identified sRNAs are mainly located on chromosome 1 (Fig. 3A), with an average length of approximately 200 nucleotides (Fig. 3B). Most of their sequences are conserved amongst B. cenocepacia strains, with only 15% not conserved (Fig. 3C; Supplemental Table S9). About 65% of the identified sRNAs were conserved or semi-conserved amongst Bcc members. The number of conserved sRNAs is relatively low in the phylogenetic related group of Burkholderia pseudomallei, which can cause melioidosis in humans (Sawana et al. 2014). Of the 168 sRNAs previously described in Bcc (Pita et al. 2018), 31 were found to be expressed in the conditions tested in this work, but only 22 were identified (Supplemental Table S9) using the established sRNA identification methodology, which excluded the NCBI annotated sRNAs. Thirteen sRNAs previously identified in B. cenocepacia biofilms were found to be expressed in our dataset, and 7 of them were found to be dysregulated in B. cenocepacia during C. elegans infection (Sass et al. 2017) (Supplemental Table S9).

Fig. 3.

Fig. 3

Genomic distribution and characteristics of the B. cenocepacia J2315 sRNAs identified in this work. A TSS and sRNA distribution by replicon. Plus: positive or sense strand; minus: negative or antisense strand. B sRNA length distribution. The average sRNA length is 200 nts, which is represented by the Gaussian distribution. C sRNA conservation. The majority of the identified sRNAs are conserved in B. cenocepacia, conserved or semi-conserved in Bcc, and non-conserved in B. pseudomallei group (classification criteria are detailed in Supplemental Table S9)

The first two columns show the differential gene expression relative to a fold change of the 6 sRNAs selected, measured during C. elegans infection relative to controls, and their conservation level. The predicted targets were identified by the locus tag and the virulence factors were highlighted in bold. The function of the predicted targets, their differential expression during C. elegans infection, the location of the predicted sRNA binding region, and the statistical significance of the predicted interaction were also included. The p-values were predicted for the probability of finding an interaction in random sequences with a score greater than or equal to the score of the observed interaction and were represented by * when the p-value < 0.05, ** when the p-value < 0.01, *** when the p-value < 0.001, and **** when the p-value < 0.0001.

aGenes that were not directly identified by bioinformatics tools. The binding regions identified as being upstream of the targets predicted and listed on Supplemental Table S10 are in fact located on the genes listed in this table. The targets predicted were BCAL1262, BCAM1946, BCAL2829, BCAL1675, and BCAL3515.

bThe differential expression mentioned refers to the first gene of the operon from which this gene is transcribed.

RIT2a, RIT11b, RIT32, RIT43, RIT55, and RIT98 are sRNAs directly affecting B. cenocepacia virulence?

Based on the different levels of expression between control and infection samples, degree of conservation amongst Bcc members, and predicted targets, 5 sRNAs were selected for further characterization: RIT11b, RIT32, RIT43, RIT55, and RIT98, that were previously identified by Sass et al. (2017) as ncS06, ncS16, nc5U42, ncS11, and ncRI12, respectively. RIT11b, RIT32, and RIT55 were downregulated in infection samples, with a fold change of − 4, − 27, and − 153, respectively, whereas RIT43 and RIT98 were upregulated, with a fold change of 8 and 59, respectively (Table 2 and Supplemental Table S9). RIT2a, previously identified as ncS01 (Sass et al. 2017), was also selected due to the high expression and high conservation levels amongst Bcc and B. pseudomallei group species. Despite the high level of expression, this sRNA was not found as differentially expressed under infection conditions compared to controls. All the 6 selected sRNAs are highly conserved amongst Bcc species and RIT32, RIT55, and RIT98 are also conserved amongst the B. pseudomallei group (Table 2 and Supplemental Table S9). TargetRNA2 and CopraRNA were used to predict the targets of the selected sRNAs. Amongst the predicted targets, genes coding for virulence factors, sigma factors, and genes required for Bcc survival in different environments were selected (Table 2). To increase the probability of selecting direct targets of these sRNAs, the location of the predicted RNA-RNA interaction site on the mRNA was also considered in the analysis of the targets that are most likely to bind directly to each sRNA. Amongst the selected sRNAs, RIT11b presented the highest number of predicted targets, nine of them encoding virulence factors.

Table 2.

Predicted targets for the selected sRNAs RIT2a, RIT11b, RIT32, RIT43, RIT55, and RIT98

Predicted targets
sRNA/DF C. elegans Conservation NCBI locus tag Function/system Regulation TargetRNA2 CopraRNA

RIT2a (ncS01)

 + 1.35x

Bcc BCAM1011 EPS biosynthesis - 51|68**** 52|67***
BCAL1261a carAB operon Upb 417|435**** 419|443**
BCAM2060 Metal ion transport Up - 12|29*
BCAM1947a RND-9 efflux pump - 1096|1106** -
BCAL3233 Glycosyltransferase Up 4|16* -

RIT11b (ncS06)

 − 3.74x

Bcc BCAL1625 tRNA processing Up 51|65****  − 35|37*
BCAL3116 Glycosyltransferase -  − 1|16****  − 198|− 149*
BCAL0481 PG biosynthesis - 1|32**** 64|100*
BCAM2688 Isomerase -  − 15|1**  − 66|19*
BCAL3351 Pyrimidine biosynthesis Up 37|65* 5|100*
BCAL0207 Oxidative stress resp. - -  − 38|− 5*
BCAL0276 Type IV pilus -  − 153|− 139* -
BCAL0337 Type VI secretion Upb 4|31* -
BCAL2011 Two-component system Up - 43|72*
BCAL2830a Two-component system - 1328|1345**** -
BCAL3503 Flagellar biosynthesis - - 32|65*
BCAM1867 Macrophage survival Up  − 138|− 120** -
BCAM2107 Oxidative stress resp. -  − 132|− 118* -
BCAM2169 Membrane transporter Down  − 156|− 138* -

RIT32 (ncS16)

 − 26.66x

Bcc

B. pseudomallei

BCAS0099 LacI family regulator Up  − 68|− 37*  − 66|− 37*
BCAM0918 Sigma factor RpoD - -  − 299|− 255*
BCAM2057 Type III secretion - -  − 24|− 7**
BCAM1946 RND-9 efflux pump - -  − 21|− 2*
BCAS0104 Cell adhesion -  − 15|− 6* -
BCAL0113 Cell adhesion -  − 18|3* -
BCAL0824 C. elegans survival - -  − 68|− 4*
BCAL3471 Cell division Up - 40|96***

RIT43 (nc5U42)

 + 7.73x

Bcc BCAL2349 Ribosomal protein S15 - 35|55**  − 111|− 96**
BCAL3400 Pyrimidine biosynthesis -  − 64|− 49* -
BCAL1995 AHL, quorum sensing - - 0|21***
BCAL0739 Phosphoglyceromutase - -  − 55|− 32*
BCAL0401 Pentose-phosphate shunt - -  − 60|− 7**

RIT55 (ncS11)

 − 153.25x

Bcc

B. pseudomallei

BCAL2830 Two-component system - - 47|78*
BCAL2211 Two-component system - -  − 153|− 129**
BCAL1369 Sigma factor 70 EcfC - -  − 156|− 119*
BCAL3152 Sigma factor - -  − 107|− 44**
BCAL1674a RND-3 efflux pump - - 1059|1108**
BCAM2060 Metal ion transport - -  − 104|− 68*

RIT98 (ncRI12)

 + 59.06x

Bcc

B. pseudomallei

BCAS0104 Cell adhesion -  − 14|− 5* -
BCAL0959 Cell adhesion -  − 18|− 5* -
BCAL3121 O-antigen biosynthesis - -  − 90|10**
BCAL3152 Sigma factor - -  − 85|− 61*
BCAL3516a Type II secretion - - 391|484*

To evaluate the direct effect of the selected sRNAs on B. cenocepacia virulence towards the C. elegans infection model, slow-killing assays were conducted using B. cenocepacia K56-2 (a strain very close to B. cenocepacia J2315 but genetically easier to handle) carrying pIN29 derivative plasmids overexpressing RIT11b, RIT32, or RIT55, or silencing RIT2a, RIT43, or RIT98. We choose to overexpress RIT11b, RIT32, or RIT55, and silence RIT2a, RIT43, or RIT98, since our results show that these sRNAs were, respectively, downregulated or upregulated in infection conditions compared to controls. Infection assays reveal that the overexpression of RIT11b in B. cenocepacia K56-2 attenuated the virulence of this strain in C. elegans infection model, whilst the RIT43 silencing had the opposite effect (Fig. 4A, B). In in vitro conditions, both RIT11b overexpression and RIT43 silencing were confirmed by qRT-PCR in B. cenocepacia K56-2 carrying the pTAP3 and the pTAP11 plasmids, respectively (Fig. 4C). No effect in B. cenocepacia virulence in C. elegans infection model was detected when RIT2a or RIT98 was repressed, or when RIT32 or RIT55 was overexpressed (Supplemental Fig. S2). The overexpression of RIT11b or silencing of RIT43 did not affect the growth kinetics of B. cenocepacia K56-2, thus indicating that the effects observed in virulence were not due to impaired bacterial growth (Fig. 4D). The attenuated virulence of B. cenocepacia observed with RIT11b overexpression is in agreement with our RNA-seq data, where RIT11b was downregulated in B. cenocepacia during C. elegans infection. Despite the upregulation of RIT43 under infection conditions, an increased virulence of B. cenocepacia was observed when RIT43 was silenced by our antisense strategy. This effect may be due to an unknown effect of the selected antisense sequence to silence this sRNA or to a compensatory effect by another regulator.

Fig. 4.

Fig. 4

Effect of RIT11b overexpression and RIT43 silencing in B. cenocepacia K56-2. A and B Kaplan–Meier survival plots of C. elegans infected with B. cenocepacia K56-2 carrying the empty vector pIN29 (control), the pTAP3 plasmid overexpressing RIT11b (A), or the pTAP11 plasmid silencing RIT43 using an antisense strategy (B). Survival curves show the results of three representative independent assays. Log-rank (Mantel-Cox) test was used to determine significance of survival differences. C Relative expression levels of the sRNAs RIT11b and RIT43 quantified by qRT-PCR. Multiple t tests (one per row) were used to determine statistical significance. D Bacterial growth curves in rich medium (LB), monitored by optical density at 640 nm. C and D graphs show the mean ± SD from a representative of three independent assays. Statistical significance is represented in accordance with p-value, *p-value < 0.05, **p-value < 0.01, and ****p-value < 0.0001

RIT11b is a virulence regulator in B. cenocepacia

The role played by RIT11b on the virulence of B. cenocepacia K56-2 towards C. elegans led us to hypothesise RIT11b as a negative regulator of the expression of genes required for B. cenocepacia virulence. Out of the predicted targets for RIT11b (Table 2), BCAL1625 and BCAL3351 genes stand out as the RIT11b sole targets identified by the two bioinformatics tools used as being upregulated under infection conditions. BCAL1625 encodes the tRNA-dihydrouridine synthase A (DusA), whilst BCAL3351 encodes the dihydroorotase PyrC. The dusA and pyrC downregulation observed when RIT11b was overexpressed suggests that both dusA and pyrC mRNAs are regulated by RIT11b (Fig. 5A). Electrophoretic mobility shift assays (EMSA) using increasing concentrations of RIT11b showed that in vitro this sRNA directly interacts with dusA and pyrC mRNAs (Fig. 5B, C).

Fig. 5.

Fig. 5

Effect of RIT11b overexpression in B. cenocepacia K56-2. A Regulatory effect of RIT11b in two predicted targets. Relative expression levels of the mRNAs dusA and pyrC, when RIT11b is overexpressed in B. cenocepacia K56-2 (pTAP3 plasmid). B and C Electrophoretic mobility shift assay (EMSA). Interactions between the unlabelled sRNA RIT11b and the labelled BCAL1625 (B) or BCAL3351 (C) RNAs. D RIT11b impairs biofilm formation. Comparison of the amount of biofilm formed by B. cenocepacia K56-2 with pIN29 or pTAP3 plasmids in polystyrene microtitre plates, after 24 h or 48 h of growth in LB medium. E RIT11b increases the B. cenocepacia motility. Quantification of the swimming motility diameter of bacterial cells at 24, 48, and 72 h after inoculation onto swimming agar plates. B. cenocepacia K56-2 carrying the pIN29 plasmid was used as control. All graphs show the mean ± SD from a representative of three independent assays. Two-way ANOVA was used to assess the statistical significance of biofilm formation and swimming motility, represented in accordance with the p-value, *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001, and ****p-value < 0.0001

In addition to dusA and pyrC, many other targets were predicted for RIT11b, mostly related to the cell wall and membrane-associated mechanisms, namely peptidoglycan biosynthesis, lipopolysaccharide (LPS) O-antigen biosynthesis, epithelial cell adhesion, and biofilm formation, suggesting a role on host colonization and invasion. In vitro assays were performed to determine whether RIT11b would be involved in regulating the motility and biofilm formation of B. cenocepacia. The overexpression of RIT11b reduced biofilm formation, especially after 48 h of growth, and promoted swimming motility in B. cenocepacia K56-2 (Fig. 5 D and E). Considering all the results obtained, we hypothesise that RIT11b is a pleiotropic regulator in B. cenocepacia.

Discussion

Despite the advances in therapies, infections by B. cenocepacia and other Bcc bacteria remain a life-threatening to CF patients due to their resistance to multiple antibiotics, and the unpredictable outcome of infections. Understanding the molecular details and mechanisms underlying the contribution of sRNAs to Bcc bacteria-host interaction is expected to allow the identification of potential interesting targets for the rational development of novel strategies to combat infections caused by Bcc, as well as to predict the outcome of infections caused by these bacteria. Although several studies have identified more than a hundred putative sRNAs encoded within the genome of B. cenocepacia J2315, there is an obvious lack of knowledge regarding the non-coding virulome of these bacteria.

A methodology to unveil the B. cenocepacia non-coding transcriptome under real infection conditions was developed in this work using C. elegans as infection model. Over the past two decades, the nematode C. elegans has been used as an infection model to assess the impact of some genes on virulence of Bcc bacteria (Köthe et al. 2003; Hunt et al. 2004; Cardona et al. 2005). Pleiotropic regulators, genes involved in quorum-sensing mechanisms, lipopolysaccharide O-antigen biosynthesis, general stress responses and in nutrient acquisition have been shown to attenuate the virulence of these bacteria in C. elegans (Köthe et al. 2003; Sousa et al. 2010; Wong et al. 2018). Considering the poor characterization of the B. cenocepacia non-coding virulome, this infection model was used to identify sRNAs that are involved in bacterial virulence and to try to establish an association with the predicted targets that are also involved in this process. As the main objective was the identification of sRNAs that control the B. cenocepacia virulence, samples collected under infection conditions and controls were sequenced by Cappable-seq, a method that enables a robust TSS determination in bacteria (Ettwiller et al. 2016). This methodology allowed the identification of 8695 TSSs under the tested conditions. Although using distinct methods and conditions, 10843 TSSs were previously identified in B. cenocepacia biofilms using a differential RNA-sequencing methodology, which were cut off to 4010 TSSs after filtering on a minimum of 10 read starts (Sass et al. 2015). Similarly, under biofilm growth conditions, 2089 genes (28% of the annotated genes) were found to be transcribed by B. cenocepacia (Sass et al. 2015), close to the 2584 genes identified in this work. Thirty-two percent of the 2584 expressed genes were found to be differentially expressed under infection conditions. The highest percentage of differently expressed genes was found in chromosome 1, which contains a higher proportion of coding sequences involved in core functions, such as DNA replication, protein synthesis, energy metabolism, and cell wall biosynthesis (Wong et al. 2016). In this work, genes related with metabolic pathways, amino acid biosynthesis, translation functions, and LPS biosynthesis were also found to be significantly dysregulated in B. cenocepacia infecting C. elegans (Fig. 2E), suggesting that the infection process requires a fine tuning of core cellular processes and pathways. Previously, Yoder-Himes et al. (2009) found that under CF conditions, B. cenocepacia responds primarily by expressing core housekeeping genes mainly encoded on chromosome 1 (Yoder-Himes et al. 2009). Furthermore, Pimenta et al. (2021) also reported that during the early contacts with giant plasma membrane vesicles (GPMVs) derived from live bronchial epithelial cells, general metabolic pathways are significantly dysregulated. These metabolic changes have also been observed in other bacterial pathogens. Alterations in infection-specific gene expression related with transport and metabolism of amino acids and transcription functions were observed in V. parahaemolyticus during all the infection process of C. elegans (12–48 h). In addition, genes enriched in translation functions, membrane biogenesis, and energy production were significantly induced at the late stages of infection (Zhang et al. 2020). Still, the most significantly altered KEGG pathway was the biosynthesis of secondary metabolites. These molecules can be antibiotics, mycotoxins, plant growth factors, fungal elicitors, plant and animal host defensins, and quorum-sensing molecules, playing a crucial role in the interactions of bacteria with other surrounding organisms (Martín et al. 2005).

Most of the virulence factors expressed under infection conditions were found to be upregulated during C. elegans infection and are mostly related to processes regarding bacteria sensing and interaction with the surrounding environment. Two of the those genes were the extracytoplasmic function sigma factors orbS and ecfD, which in Burkholderia species are activated by iron limitation conditions, managing the production and secretion of siderophores, which chelate iron and facilitate its cellular uptake, constituting an important mechanism for bacterial virulence (Grove 2022). The genes that code for the Hfq chaperone and the LysR family protein ShvR, two pleiotropic regulators, were found to be dysregulated in B. cenocepacia J2315 during C. elegans infection (Supplemental Table S6). Hfq is involved in the regulation of virulence traits related to secretion systems, alternative sigma factors, outer membrane proteins, polysaccharides, and iron metabolism, and impacts the pathogenicity of several bacterial pathogens, including Bcc bacteria (Sousa et al. 2010; Feliciano et al. 2016). The increased expression of Hfq chaperone under infection conditions strongly suggests that the infection process is post-transcriptionally regulated through small RNAs. ShvR influences the expression of genes for quorum sensing, protease, type II secretion system, and afc genes. In B. cenocepacia, this regulator is important for biofilm formation, inflammation in a rat lung infection model, and is required for the induction of fatal proinflammatory responses in zebrafish larvae (Subramoni et al. 2011; Gomes et al. 2018). These results highlight the importance of the expression of some virulence factors for the adaptation and successful infections caused by B. cenocepacia.

Regarding the non-coding transcriptome, the data analysis focused only on the TSSs identified in the intergenic regions and on the presence of Rho terminators in the vicinity of these TSSs, limiting the number of sRNAs obtained. Of the sRNAs identified by the methodology developed, 108 were described here for the first time, as well as 22 previously described, thus validating our approach. This is a major contribution to the identification of the B. cenocepacia non-coding genome, especially to find sRNAs differently expressed under infection conditions. Amongst the already described sRNAs, some sRNAs previously identified in B. cenocepacia biofilms were found to be dysregulated in B. cenocepacia during C. elegans infection, like the ncS35 sRNA. The ncS35 sRNA was described as a sRNA that can reduce the metabolic rate and growth, possibly to protect B. cenocepacia against stressors, and increase the bacterial survival under unfavourable conditions, like the ones found in host–pathogen interactions (Kiekens et al. 2018). The upregulation of this sRNA in B. cenocepacia during C. elegans infection may be important to finely tune the expression genes involved in metabolic pathways that are determinant for B. cenocepacia adaptation to host environment.

To understand whether the identified sRNAs directly affected the virulence of B. cenocepacia against C. elegans, six sRNAs were selected for further characterization based on their differential expression in C. elegans infection, high conservation amongst Bcc strains, and their predicted targets. Regarding the predicted targets, those coding for virulence factors, sigma factors, and genes required for Bcc survival in different environments were preferentially selected. Although several genes involved in B. cenocepacia virulence are predicted targets of the RIT2a, RIT32, RIT55, and RIT98 sRNAs, under the tested conditions it was not possible to establish a direct effect of the expression of these sRNAs and B. cenocepacia virulence. However, the sRNA RIT11b, which was found as downregulated under infection conditions, has proved to be involved in B. cenocepacia virulence. RIT11b was overexpressed in B. cenocepacia K56-2 and attenuated the bacterium virulence in C. elegans, highlighting the active role of this sRNA in virulence.

Virulence factors involved in stress responses, secretion systems, motility, and macrophage survival were predicted targets of RIT11b, and some of them (BCAL2011, BCAM1867, BCAL0337, BCAL1625, and BCAL3351) were found to be upregulated in B. cenocepacia during C. elegans infection. In addition to be upregulated, dusA (BCAL1625) and pyrC (BCAL3351) have also been described to be involved in bacterial virulence, and we showed in vitro the direct binding of RIT11b with the mRNA of these two genes. qRT-PCR assays revealed that dusA and pyrC can be negatively regulated by RIT11b. PyrC, a key player of pyrimidine nucleobase biosynthetic process, was also found to be overexpressed in P. aeruginosa during chronic infections (Winsor et al. 2008; Naughton et al. 2011), suggesting that the C. elegans infection process by B. cenocepacia resembles a chronic infection. Regarding DusA, this protein was previously identified as essential for B. cenocepacia survival in C. elegans (Wong et al. 2018). The dus genes family have been found to be downregulated during heat shock stress in Clostridium botulinum, in E. coli upon cell death mediated by bactericidal antibiotics, or in Bdellovibrio bacteriovorus predation (Kohanski et al. 2007; Lambert et al. 2010; Liang et al. 2013). The dusB deletion mutant was also associated with a reduced biofilm production by P. aeruginosa and Actinobacillus pleuropneumoniae (Müsken et al. 2010; Grasteau et al. 2011). Interestingly, dusA deletion significantly reduced Neisseria meningitidis adherence to human epithelial cells (Hey et al. 2013). Bacterial adherence is also fundamental for host colonization by B. cenocepacia and the bacterium pathogenicity (Leitão et al. 2010; Kumar et al. 2020). Therefore, we hypothesise that DusA plays a role in B. cenocepacia similar to the N. meningitidis homologue.

Many other targets were also predicted for RIT11b, mostly related to the cell wall and membrane-associated mechanisms, namely peptidoglycan biosynthesis, lipopolysaccharide (LPS) O-antigen biosynthesis, epithelial cell adhesion, and biofilm formation, suggesting a pleiotropic role of this sRNA on host colonization and invasion. When overexpressed in B. cenocepacia K56-2, RIT11b reduced biofilm formation and promoted swimming motility. This negative correlation between the biofilm formation and swimming motility was also recently described by Sass et al. (2022) when increasing the expression of wspH in B. cenocepacia (Sass et al. 2022). The overexpression of wspH, a two-component hybrid system kinase-response regulator protein, led to accelerated pellicle biofilm formation and reduced swimming motility. This kinase had previously been described as a biofilm regulator and was linked to the formation of small colony variants (SCVs) (Cooper et al. 2014). Curiously, when we predicted the interaction between wspH mRNA and RIT11b sRNA using IntaRNA, multiple-interaction sites were predicted (energy score of the predicted interactions: − 14 to − 6.6 kcal/mol). The impaired biofilm formation and the increased swimming motility observed when RIT11b was overexpressed in B. cenocepacia J2315 might result from a downregulation of wspH by RIT11b.

Several other sRNAs have been described as pleiotropic modulators of bacterial virulence, such as P. aeruginosa RsmZ, ReaL, ErsA, and SrbA (Liu et al. 2022); Staphylococcus aureus RsaA and Teg49 (Menard et al. 2022); and E. coli and Salmonella enterica McaS, OmrA, and OxyS (Mitra and Mukhopadhyay 2023). Therefore, whilst most of these sRNAs positively modulate bacterial virulence and biofilm formation, RIT11b was downregulated when B. cenocepacia was infecting C. elegans and its overexpression reduced bacterial virulence and biofilm formation. OmrA and RydC, in Gram-negative bacteria, and AscicR and csRNA1-1, in Gram-positive bacteria, are some of the few sRNAs that also negatively modulate biofilm formation (Mitra and Mukhopadhyay 2023).

Knowledge on the regulatory roles of sRNAs is crucial to understand mechanisms underlying bacterial infection and host–pathogen interaction processes, and to find novel ways to control infections. A closer look to less obvious targets, like dusA and pyrC, is also required due to their importance for bacteria virulence. Beyond dusA and pyrC, multiple and diverse targets were predicted for RIT11b, from quorum-sensing to pyrimidine metabolism. Also, in addition to the role played by RIT11b on B. cenocepacia virulence, changes in biofilm formation ability and motility were also observed when RIT11b was overexpressed, suggesting that other targets should be regulated by this sRNA. We therefore hypothesise that RIT11b is a pleiotropic regulator impacting the ability of B. cenocepacia to infect a host, being the first characterization of a sRNAs directly involved in B. cenocepacia virulence.

Supplementary Information

Below is the link to the electronic supplementary material.

Author contribution

J. H. L., J. R. F., and T. P. conceived and designed the research. T. P. and J. R. F. conducted the experiments. J. H. L. managed the project funding. T. P. and J. R. F analysed the data. T. P. wrote the manuscript. J. H. L. and J. R. F. revised the manuscript. All authors read and approved the manuscript.

Funding

Open access funding provided by FCT|FCCN (b-on). A PhD grant (PD/BD/135137/2017) from FCT-PhD program BIOTECnico was provided to T. P. This study was funded by Fundação para a Ciência e a Tecnologia (grant numbers 2022.07091.PTDC, PTDC/BIA-MIC/1615/2014, UIDB/04565/2020, UIDP/04565/2020, and LA/P/0140/2020).

Data availability

All data generated or analysed during this study are included in this published article, as supplementary information files. Cappable-seq data is available under Array Express accession number E-MTAB-12592.

Declarations

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

Conflict of interest

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Tiago Pita, Email: tiagopita@tecnico.ulisboa.pt.

Joana R. Feliciano, Email: joana.feliciano@tecnico.ulisboa.pt

Jorge H. Leitão, Email: jorgeleitao@tecnico.ulisboa.pt

References

  1. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71–94. doi: 10.1093/genetics/77.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bu D, Luo H, Huo P, Wang Z, Zhang S, He Z, Wu Y, Zhao L, Liu J, Guo J, Fang S, Cao W, Yi L, Zhao Y, Kong L. KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis. Nucleic Acids Res. 2021;49:W317–W325. doi: 10.1093/nar/gkab447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cardona ST, Wopperer J, Eberl L, Valvano MA. Diverse pathogenicity of Burkholderia cepacia complex strains in the Caenorhabditis elegans host model. FEMS Microbiol Lett. 2005;250:97–104. doi: 10.1016/j.femsle.2005.06.050. [DOI] [PubMed] [Google Scholar]
  4. Chen J, Morita T, Gottesman S. Regulation of transcription termination of small RNAs and by small RNAs: molecular mechanisms and biological functions. Front Cell Infect Microbiol. 2019;9:201. doi: 10.3389/fcimb.2019.00201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cooper VS, Carlson WA, LiPuma JJ. Susceptibility of Caenorhabditis elegans to Burkholderia infection depends on prior diet and secreted bacterial attractants. PLoS One. 2009;4:e7961. doi: 10.1371/journal.pone.0007961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooper VS, Staples RK, Traverse CC, Ellis CN. Parallel evolution of small colony variants in Burkholderia cenocepacia biofilms. Genomics. 2014;104:447–452. doi: 10.1016/j.ygeno.2014.09.007. [DOI] [PubMed] [Google Scholar]
  7. Cunha MV, Sousa SA, Leitão JH, Moreira LM, Videira PA, Sá-Correia I. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol. 2004;42:3052–3058. doi: 10.1128/JCM.42.7.3052-3058.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Darling P, Chan M, Cox AD, Sokol PA. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun. 1998;66:874–877. doi: 10.1128/IAI.66.2.874-877.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. de Dios R, Santero E, Reyes-Ramírez F. Extracytoplasmic function σ factors as tools for coordinating stress responses. Int J Mol Sci. 2021;22(8):3900. doi: 10.3390/ijms22083900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Déziel E, Comeau Y, Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J Bacteriol. 2001;183:1195–1204. doi: 10.1128/JB.183.4.1195-1204.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Djapgne L, Oglesby AG. Impacts of small RNAs and their chaperones on bacterial pathogenicity. Front Cell Infect Microbiol. 2021;11:604511. doi: 10.3389/fcimb.2021.604511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ettwiller L, Buswell J, Yigit E, Schildkraut I. A novel enrichment strategy reveals unprecedented number of novel transcription start sites at single base resolution in a model prokaryote and the gut microbiome. BMC Genomics. 2016;17:1–14. doi: 10.1186/s12864-016-2539-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Feliciano JR, Grilo AM, Guerreiro SI, Sousa SA, Leitão JH. Hfq: a multifaceted RNA chaperone involved in virulence. Future Microbiol. 2016;11:137–151. doi: 10.2217/fmb.15.128. [DOI] [PubMed] [Google Scholar]
  14. Feliciano JR, Seixas AMM, Pita T, Leitão JH. Comparative genomics and evolutionary analysis of RNA-binding proteins of Burkholderia cenocepacia J2315 and other members of the B. cepacia complex. Genes (basel) 2020;11:1–23. doi: 10.3390/genes11020231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Golshahi L, Lynch KH, Dennis JJ, Finlay WH. In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. J Appl Microbiol. 2011;110:106–117. doi: 10.1111/j.1365-2672.2010.04863.x. [DOI] [PubMed] [Google Scholar]
  16. Gomes MC, Tasrini Y, Subramoni S, Agnoli K, Feliciano JR, Eberl L, Sokol P, O’Callaghan D, Vergunst AC. The afc antifungal activity cluster, which is under tight regulatory control of ShvR, is essential for transition from intracellular persistence of Burkholderia cenocepacia to acute pro-inflammatory infection. PLoS Pathog. 2018;14:e1007473. doi: 10.1371/journal.ppat.1007473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Govan JRW, Doherty CJ, Nelson JW, Brown PH, Greening AP, Maddison J, Dodd M, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993;342:15–19. doi: 10.1016/0140-6736(93)91881-L. [DOI] [PubMed] [Google Scholar]
  18. Grasteau A, Tremblay YDN, Labrie J, Jacques M. Novel genes associated with biofilm formation of Actinobacillus pleuropneumoniae. Vet Microbiol. 2011;153:134–143. doi: 10.1016/j.vetmic.2011.03.029. [DOI] [PubMed] [Google Scholar]
  19. Grove A. Extracytoplasmic function sigma factors governing production of the primary siderophores in pathogenic Burkholderia species. Front Microbiol. 2022;13:851011. doi: 10.3389/fmicb.2022.851011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hassan AA, dos Santos SC, Cooper VS, Sá-Correia I. Comparative evolutionary patterns of Burkholderia cenocepacia and B multivorans during chronic co-infection of a cystic fibrosis patient lung. Front Microbiol. 2020;11:2330. doi: 10.3389/fmicb.2020.574626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hassan AA, Vitorino MV, Robalo T, Rodrigues MS, Sá-Correia I. Variation of Burkholderia cenocepacia cell wall morphology and mechanical properties during cystic fibrosis lung infection, assessed by atomic force microscopy. Sci Rep. 2019;9:16118. doi: 10.1038/s41598-019-52604-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hey A, Li MS, Hudson MJ, Langford PR, Simon Krolla J. Transcriptional profiling of Neisseria meningitidis interacting with human epithelial cells in a long-term in vitro colonization model. Infect Immun. 2013;81:4149–4159. doi: 10.1128/IAI.00397-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Holden MTG, Seth-Smith HMB, Crossman LC, Sebaihia M, Bentley SD, Cerdeño-Tárraga AM, Thomson NR, Bason N, Quail MA, Sharp S, Cherevach I, Churcher C, Goodhead I, Hauser H, Holroyd N, Mungall K, Scott P, Walker D, White B, Rose H, Iversen P, Mil-Homens D, Rocha EPC, Fialho AM, Baldwin A, Dowson C, Barrell BG, Govan JR, Vandamme P, Hart CA, Mahenthiralingam E, Parkhill J. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol. 2009;91:261–277. doi: 10.1128/JB.01230-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hope IA (1999) Caenorhabditis elegans: a practical approach. Oxford University Press, Oxford
  25. Hunt TA, Kooi C, Sokol PA, Valvano MA. Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun. 2004;72:4010–4022. doi: 10.1128/IAI.72.7.4010-4022.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kaletsky R, Moore RS, Vrla GD, Parsons LR, Gitai Z, Murphy CT. C. elegans interprets bacterial non-coding RNAs to learn pathogenic avoidance. Nature. 2020;586:445–451. doi: 10.1038/s41586-020-2699-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kery MB, Feldman M, Livny J, Tjaden B. TargetRNA2: Identifying targets of small regulatory RNAs in bacteria. Nucleic Acids Res. 2014;42:124–129. doi: 10.1093/nar/gku317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kiekens S, Sass A, Van Nieuwerburgh F, Deforce D, Coenye T (2018) The small RNA ncS35 regulates growth in Burkholderia cenocepacia J2315. mSphere 3:1–16 10.1128/msphere.00579-17 [DOI] [PMC free article] [PubMed]
  29. Kingsford CL, Ayanbule K, Salzberg SL. Rapid, accurate, computational discovery of Rho-independent transcription terminators illuminates their relationship to DNA uptake. Genome Biol. 2007;8:R22. doi: 10.1186/gb-2007-8-2-r22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130:797–810. doi: 10.1016/j.cell.2007.06.049. [DOI] [PubMed] [Google Scholar]
  31. Köthe M, Antl M, Huber B, Stoecker K, Ebrecht D, Steinmetz I, Eberl L. Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep quorum-sensing system. Cell Microbiol. 2003;5:343–351. doi: 10.1046/j.1462-5822.2003.00280.x. [DOI] [PubMed] [Google Scholar]
  32. Kumar A, Baruah A, Tomioka M, Iino Y, Kalita MC, Khan M. Caenorhabditis elegans: a model to understand host–microbe interactions. Cell Mol Life Sci. 2020;77:1229–1249. doi: 10.1007/s00018-019-03319-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lai CH, Chou CY, Ch’ang LY, Liu CS, Lin WC. Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res. 2000;10:703–713. doi: 10.1101/gr.10.5.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lambert C, Ivanov P, Sockett RE. A transcriptional “scream” early response of E. coli prey to predatory invasion by Bdellovibrio. Curr Microbiol. 2010;60:419–427. doi: 10.1007/s00284-009-9559-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Leitão JH, Feliciano JR, Sousa SA, Pita T, Guerreiro SI (2017) Burkholderia cepacia complex infections among cystic fibrosis patients: perspectives and challenges. In: Sriramulu D (ed) Progress in understanding cystic fibrosis. InTech, London, 73 - 100 10.5772/67712
  36. Leitão JH, Sousa SA, Ferreira AS, Ramos CG, Silva IN, Moreira LM. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species. Appl Microbiol Biotechnol. 2010;87:31–40. doi: 10.1007/s00253-010-2528-0. [DOI] [PubMed] [Google Scholar]
  37. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R; 1000 Genome Project Data Processing Subgroup The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078–2079. doi: 10.1093/bioinformatics/btp352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Liang WD, Bi YT, Wang HY, Dong S, Li KS, Li JS. Gene expression profiling of Clostridium botulinum under heat shock stress. Biomed Res Int. 2013;2013:760904. doi: 10.1155/2013/760904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Liu P, Yue C, Liu L, Gao C, Lyu Y, Deng S, Tian H, Jia X. The function of small RNA in Pseudomonas aeruginosa. PeerJ. 2022;10:e13738. doi: 10.7717/peerj.13738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  41. Mann M, Wright PR, Backofen R. IntaRNA 2.0: enhanced and customizable prediction of RNA-RNA interactions. Nucleic Acids Res. 2017;45:W435–W439. doi: 10.1093/nar/gkx279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Marsh JW, Humphrys MS, Myers GSA. A laboratory methodology for dual RNA-sequencing of bacteria and their host cells in vitro. Front Microbiol. 2017;8:1830. doi: 10.3389/fmicb.2017.01830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Martín JF, Casqueiro J, Liras P. Secretion systems for secondary metabolites: how producer cells send out messages of intercellular communication. Curr Opin Microbiol. 2005;8:282–293. doi: 10.1016/j.mib.2005.04.009. [DOI] [PubMed] [Google Scholar]
  44. Martina P, Leguizamon M, Prieto CI, Sousa SA, Montanaro P, Draghi WO, Stämmler M, Bettiol M, de Carvalho CCCR, Palau J, Figoli C, Alvarez F, Benetti S, Lejona S, Vescina C, Ferreras J, Lasch P, Lagares A, Zorreguieta A, Leitão JH, Yantorno OM, Bosch A. Burkholderia puraquae sp. nov., a novel species of the Burkholderia cepacia complex isolated from hospital settings and agricultural soils. Int J Syst Evol Microbiol. 2018;68:14–20. doi: 10.1099/ijsem.0.002293. [DOI] [PubMed] [Google Scholar]
  45. Mejía-Almonte C, Busby SJW, Wade JT, van Helden J, Arkin AP, Stormo GD, Eilbeck K, Palsson BO, Galagan JE, Collado-Vides J. Redefining fundamental concepts of transcription initiation in bacteria. Nat Rev Genet. 2020;21:699–714. doi: 10.1038/s41576-020-0254-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Menard G, Silard C, Suriray M, Rouillon A, Augagneur Y. Thirty years of sRNA-mediated regulation in Staphylococcus aureus: from initial discoveries to in vivo biological implications. Int J Mol Sci. 2022;23(13):7346. doi: 10.3390/ijms23137346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Metsalu T, Vilo J. ClustVis: A web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 2015;43:W566–W570. doi: 10.1093/nar/gkv468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mitra A, Mukhopadhyay S. Regulation of biofilm formation by non-coding RNA in prokaryotes. Curr Res Pharmacol Drug Discov. 2023;4:100151. doi: 10.1016/j.crphar.2022.100151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Müsken M, Di Fiore S, Dötsch A, Fischer R, Häussler S. Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology. 2010;156:431–441. doi: 10.1099/mic.0.033290-0. [DOI] [PubMed] [Google Scholar]
  50. Naughton S, Parker D, Seemann T, Thomas T, Turnbull L, Rose B, Bye P, Cordwell S, Whitchurch C, Manos J. Pseudomonas aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection of cystic fibrosis lung. PLoS One. 2011;6:e24526. doi: 10.1371/journal.pone.0024526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Palominos MF, Calixto A. Quantification of bacteria residing in Caenorhabditis elegans intestine. Bio-Protocol. 2020;10:e3605. doi: 10.21769/bioprotoc.3605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Pandey KD, Patel AK, Singh M, VandanaJalaluddin KA. Secondary metabolites from bacteria and viruses. In: Sinha R, Häder D-P, editors. Natural bioactive compounds. London: Academic Press; 2021. pp. 19–40. [Google Scholar]
  53. Pimenta AI, Bernardes N, Alves MM, Mil-Homens D, Fialho AM. Burkholderia cenocepacia transcriptome during the early contacts with giant plasma membrane vesicles derived from live bronchial epithelial cells. Sci Rep. 2021;11:5624. doi: 10.1038/s41598-021-85222-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Pita T, Feliciano JR, Leitão JH. Small noncoding regulatory RNAs from Pseudomonas aeruginosa and Burkholderia cepacia complex. Int J Mol Sci. 2018;19(12):3759. doi: 10.3390/ijms19123759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Pusic P, Sonnleitner E, Bläsi U. Specific and global RNA regulators in Pseudomonas aeruginosa. Int J Mol Sci. 2021;22(16):8632. doi: 10.3390/ijms22168632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841–842. doi: 10.1093/bioinformatics/btq033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Rhodes KA, Schweizer HP. Antibiotic resistance in Burkholderia species. Drug Resist Updat. 2016;28:82–90. doi: 10.1016/j.drup.2016.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Sánchez-Diener I, Zamorano L, López-Causapé C, Cabot G, Doménech-Sánchez A, Martínez-Martínez L, Arcos SC. Interplay among resistance profiles, high-risk clones, and virulence in the Caenorhabditis elegans Pseudomonas aeruginosa infection model. Antimicrob Agents Chemother. 2017;61(12):e01586–e1617. doi: 10.1128/AAC.01586-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Sass A, Kiekens S, Coenye T. Identification of small RNAs abundant in Burkholderia cenocepacia biofilms reveal putative regulators with a potential role in carbon and iron metabolism. Sci Rep. 2017;7:1–13. doi: 10.1038/s41598-017-15818-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sass A, Vandenbussche I, Bellich B, Cescutti P, Coenye T. Pellicle biofilm formation in Burkholderia cenocepacia J2315 is epigenetically regulated through WspH, a hybrid two- component system kinase-response regulator. J Bacteriol. 2022;204:e00017–22. doi: 10.1128/jb.00017-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sass AM, Coenye T. Low iron-induced small RNA BrrF regulates central metabolism and oxidative stress responses in Burkholderia cenocepacia. PLoS One. 2020;15:e0236405. doi: 10.1371/journal.pone.0236405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Sass AM, De Waele S, Daled S, Devreese B, Deforce D, Van Nieuwerburgh F, Coenye T. Small RNA NcS27 co-regulates utilization of carbon sources in Burkholderia cenocepacia J2315. Microbiology. 2019;165:1135–1150. doi: 10.1099/mic.0.000848. [DOI] [PubMed] [Google Scholar]
  63. Sass AM, Van Acker H, Förstner KU, Van Nieuwerburgh F, Deforce D, Vogel J, Coenye T. Genome-wide transcription start site profiling in biofilm-grown Burkholderia cenocepacia J2315. BMC Genomics. 2015;16:1–15. doi: 10.1186/s12864-015-1993-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Sawana A, Adeolu M, Gupta RS. Molecular signatures and phylogenomic analysis of the genus Burkholderia: proposal for division of this genus into the emended genus Burkholderia containing pathogenic organisms and a new genus Paraburkholderia gen. nov. harboring environmental species. Front Genet. 2014;5:429. doi: 10.3389/fgene.2014.00429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Sayers EW, Beck J, Bolton EE, Bourexis D, Brister JR, Canese K, Comeau DC, Funk K, Kim S, Klimke W, Marchler-Bauer A, Landrum M, Lathrop S, Lu Z, Madden TL, O’Leary N, Phan L, Rangwala SH, Schneider VA, Skripchenko Y, Wang J, Ye J, Trawick BW, Pruitt KD, Sherry ST. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2021;49:D10–D17. doi: 10.1093/nar/gkaa892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Sousa SA, Ramos CG, Almeida F, Meirinhos-Soares L, Wopperer J, Schwager S, Eberl L, Leitão JH. Burkholderia cenocepacia J2315 acyl carrier protein: a potential target for antimicrobials’ development? Microb Pathog. 2008;45:331–336. doi: 10.1016/j.micpath.2008.08.002. [DOI] [PubMed] [Google Scholar]
  67. Sousa SA, Ramos CG, Moreira LM, Leitão JH. The hfq gene is required for stress resistance and full virulence of Burkholderia cepacia to the nematode Caenorhabditis elegans. Microbiology. 2010;156:896–908. doi: 10.1099/mic.0.035139-0. [DOI] [PubMed] [Google Scholar]
  68. Subramoni S, Nguyen DT, Sokol PA. Burkholderia cenocepacia ShvR-regulated genes that influence colony morphology, biofilm formation, and virulence. Infect Immun. 2011;79:2984–2997. doi: 10.1128/IAI.00170-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Thorvaldsdóttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178–192. doi: 10.1093/bib/bbs017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Vergunst AC, Meijer AH, Renshaw SA, O’Callaghan D. Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun. 2010;78:1495–1508. doi: 10.1128/IAI.00743-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Winsor GL, Khaira B, Van Rossum T, Lo R, Whiteside MD, Brinkman FSL. The Burkholderia Genome Database: facilitating flexible queries and comparative analyses. Bioinformatics. 2008;24:2803–2804. doi: 10.1093/bioinformatics/btn524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Wong YC, El Ghany MA, Ghazzali RNM, Yap SJ, Hoh CC, Pain A, Nathan S. Genetic determinants associated with in vivo survival of Burkholderia cenocepacia in the Caenorhabditis elegans model. Front Microbiol. 2018;9:1118. doi: 10.3389/fmicb.2018.01118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Wong YC, El Ghany MA, Naeem R, Lee KW, Tan YC, Pain A, Nathan S. Candidate essential genes in Burkholderia cenocepacia J2315 identified by genome-wide TraDIS. Front Microbiol. 2016;7:1–14. doi: 10.3389/fmicb.2016.01288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Wright PR, Georg J, Mann M, Sorescu DA, Richter AS, Lott S, Kleinkauf R, Hess WR, Backofen R. CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic Acids Res. 2014;42:W119–W123. doi: 10.1093/nar/gku359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. Gene. 1985;33:103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  76. Yoder-Himes DR, Chain PSG, Zhu Y, Wurtzel O, Rubin EM, Tiedje JM, Sorek R. Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing. Proc Natl Acad Sci U S A. 2009;106:3976–3981. doi: 10.1073/pnas.0813403106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Zhang W, Xie R, Zhang XD, Lee LTO, Zhang H, Yang M, Peng B, Zheng J. Organism dual RNA-seq reveals the importance of BarA/UvrY in Vibrio parahaemolyticus virulence. Faseb J. 2020;34:7561–7577. doi: 10.1096/fj.201902630R. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

All data generated or analysed during this study are included in this published article, as supplementary information files. Cappable-seq data is available under Array Express accession number E-MTAB-12592.


Articles from Applied Microbiology and Biotechnology are provided here courtesy of Springer

RESOURCES